Improving Kinase Inhibitors: Molecular editing of resorcylic acid lactones

June 8, 2010

(PhysOrg.com) -- Given the great number and wide range of biological activities they regulate, kinases are among the most important enzyme targets for drug development efforts, particularly in the field of oncology. One of the main challenges faced by researchers in this area is inhibitor specificity; many compounds that effectively block the activity of a given target kinase also show significant inhibition of other kinases.

Nicolas Winssinger and colleagues, at the University of Strasbourg in France, have developed some promising kinase inhibitor lead compounds based on an entirely different molecular scaffold, the resorcylic acid lactones (RAL), and their results are published in ChemMedChem.

Kinases, by definition, phosphorylate their substrates, and so adenosine triphosphate (ATP) is a co-substrate common to all kinases. As many current kinase inhibitors are based on the adenosine scaffold, such compounds can often present difficulty in engineering specificity. Winssinger and co-workers focused their attention on the unique RAL pharmacophore, as various RAL-based small molecules had been shown previously to irreversibly and selectively inhibit certain kinases.

Winssinger's research group subjected the fundamental RAL pharmacophore to 'molecular editing' in order to generate two fluoroenones with improved properties; these, along with other compounds resulting from diversification of the RAL scaffold, also shed light on modifications that affect other important aspects such as metabolic stability.

"The significance of this work does not lie solely in the chemistry and IC50 values, but also in the fact that there is a tremendous interest in irreversible that can be used to engineer kinase specificity and to profile kinase activity," says Winssinger. "The cis-enone resorcylic acid lactones represent an alternative to the heterocyclic ones, which have been previously exploited. From a therapeutic perspective, compounds derived from this pharmacophore are the first irreversible of kinases involved in angiogenesis [vascular endothelial growth factor receptors (VEGFRs) and platelet-derived growth factor receptors (PDGFRs)]."

Explore further: Novel enzyme inhibitor paves way for new cancer drug

More information: Nicolas Winssinger, Molecular Editing of Kinase-Targeting Resorcylic Acid Lactones (RAL): Fluoroenone RAL, ChemMedChem 2010, 5, No. 8, 670-673, dx.doi.org/10.1002/cmdc.201000047

Related Stories

Novel enzyme inhibitor paves way for new cancer drug

May 16, 2008

Combining natural organic atoms with metal complexes, scientists at The Wistar Institute have developed a new type of enzyme inhibitor capable of blocking a biochemical pathway that plays a key role in cancer development.

Researchers unveil vital key to cancer

August 6, 2008

University of Manchester scientists have uncovered the 3-D structure of Mps1 -- a protein that regulates the number of chromosomes during cell division and thus has an essential role in the prevention of cancer -- which will ...

Yale scientists map cell signaling network

November 30, 2005

Yale University scientists have mapped, for the first time, the proteins and kinase signaling network that control how cells of higher organisms operate.

Recommended for you

Scientific advances can make it easier to recycle plastics

November 17, 2017

Most of the 150 million tons of plastics produced around the world every year end up in landfills, the oceans and elsewhere. Less than 9 percent of plastics are recycled in the United States, rising to about 30 percent in ...

The spliceosome—now available in high definition

November 17, 2017

UCLA researchers have solved the high-resolution structure of a massive cellular machine, the spliceosome, filling the last major gap in our understanding of the RNA splicing process that was previously unclear.

Ionic 'solar cell' could provide on-demand water desalination

November 15, 2017

Modern solar cells, which use energy from light to generate electrons and holes that are then transported out of semiconducting materials and into external circuits for human use, have existed in one form or another for over ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.